Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Autolus Therapeutics plc - American Depositary Shares
(NQ:
AUTL
)
2.545
+0.255 (+11.14%)
Streaming Delayed Price
Updated: 3:38 PM EDT, Aug 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Autolus Therapeutics plc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Autolus Therapeutics to hold Analyst call to highlight data at ASCO from the Pivotal Phase 2 FELIX study of obe-cel data in adult r/r B-ALL
May 22, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Via
Benzinga
Preview: Autolus Therapeutics's Earnings
↗
May 03, 2023
Via
Benzinga
The Latest Analyst Ratings for Autolus Therapeutics
↗
April 28, 2023
Via
Benzinga
Earnings Outlook For Autolus Therapeutics
↗
March 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 15, 2023
Via
Benzinga
Autolus Therapeutics announces Pivotal Phase 2 FELIX study of obe-cel in adult r/r B-ALL selected for an oral presentation at EHA
May 12, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress
May 04, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics announces Pivotal Phase 2 FELIX study of obe-cel in adult r/r B-ALL selected for an oral presentation at ASCO
April 27, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Why Autolus Therapeutics Stock Is Crashing Today
↗
December 09, 2022
The biopharmaceutical company announced the pricing of a secondary stock offering.
Via
The Motley Fool
Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner
April 27, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics Announces Publication in Molecular Therapy Nucleic Acids
April 26, 2023
- Expanding the Autolus toolkit of T-cell engineering modules against complex and immunologically hostile cancers, including solid cancer applications
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics Announces Data from AUTO1/22 Trial in Pediatric Acute Lymphoblastic Leukemia in an Oral Presentation at the EBMT 49th Annual Meeting
April 26, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics to Host Virtual Capital Markets Day
April 25, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics to Report First Quarter 2023 Financial Results and Host Conference Call on May 4, 2023
April 20, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics Announces Publication in Molecular Therapy
April 04, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics announces resignation of Chief Financial Officer
March 14, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics Has No Business Relationship with Silicon Valley Bank
March 13, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday
↗
March 08, 2023
HC Wainwright & Co. cut the price target for DURECT Corporation (NASDAQ: DRRX) from $35 to $32. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. DURECT shares fell 1.3% to close at $4.75 on...
Via
Benzinga
Autolus Therapeutics Reports Full Year 2022 Financial Results and Operational Progress
March 07, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023
February 15, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics announces Board changes
January 20, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
January 09, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs
December 21, 2022
From
Autolus Therapeutics plc
Via
GlobeNewswire
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022
December 12, 2022
From
Autolus Therapeutics plc
Via
GlobeNewswire
Dow Tumbles 100 Points; Silver Rises Over 2%
↗
December 09, 2022
U.S. stocks traded mostly lower toward the end of trading with the Dow Jones dropping 100 points on Friday
Via
Benzinga
US Stocks Turn Higher; Nasdaq Rises 40 Points
↗
December 09, 2022
U.S. stocks traded slightly midway through trading with the Nasdaq gaining over 40 points on Friday
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
December 09, 2022
Via
Benzinga
US Stocks Edge Lower; Producer Prices Increase Higher Than Expected
↗
December 09, 2022
U.S. stocks traded slightly lower this morning following the release of PPI data
Via
Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
↗
December 09, 2022
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
